Skip to main content
WeightCited

Chromium pour Insulin Resistance

B

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dchromium\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
En conclusion

            
            
Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
25

        
Études

    

    

        
2000

        
Participants

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
Note

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
Posologies couramment utilisées

                

                    
                    

                        
general:

                        
25-35 mcg/day (AI)

                    

                    
                    

                        
weightmanagement:

                        
200-1,000 mcg/day chromium picolinate

                    

                    
                    

                        
insulinsensitivity:

                        
500-1,000 mcg/day

                    

                    
                

                
                

                    Limite supérieure : No established UL; long-term safety data at >1,000 mcg/day limited
                

                
            

            

            

            
            

                Moment optimal de prise : With meals
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
Effets indésirables signalés

                    
    
                        
                        
  • 
                            ⚠
                            Headache
                        
    • 
                        
                        
  • 
                            ⚠
                            Insomnia
                        
    • 
                        
                        
  • 
                            ⚠
                            Mood changes
                        
    • 
                        
                        
  • 
                            ⚠
                            GI discomfort
                        
    • 
                        
                    

                

                

                
                

                    
Interactions connues

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may potentiate — hypoglycemia risk)
                        
    • 
                        
                        
  • 
                            ●
                            Insulin
                        
    • 
                        
                        
  • 
                            ●
                            Sulfonylureas
                        
    • 
                        
                        
  • 
                            ●
                            Levothyroxine (reduced absorption)
                        
    • 
                        
                    

                

                

                
                

                    

                        Apport maximal tolérable : No established UL; long-term safety data at >1,000 mcg/day limited
                    

                

                
            

            

                Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does Chromium help with Insulin Resistance?
            
        
        

            Based on 25 studies with 2,000 participants, there is moderate evidence from clinical studies that Chromium may support Insulin Resistance management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much Chromium should I take for Insulin Resistance?
            
        
        

            Studies have used various dosages. A commonly studied range is 25-35 mcg/day (AI). Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of Chromium?
            
        
        

            Reported side effects may include Headache, Insomnia, Mood changes, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for Chromium and Insulin Resistance?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 25 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
                
                
            

        

        

    


    
    












    

        Avertissement FDA:
        Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.